1. Gal A and Burchell RK (2023) Diabetes Mellitus and the Kidneys. Vet Clin North Am Small Anim Pract, 53(3): 565-580. [DOI:10.1016/j.cvsm.2023.01.006]

2. Geng T, Zhu K, Lu Q, Wan Z, Chen X, Liu L, Pan A, Liu G (2023) Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study. PLoS Med, 20(1): e1004135. [DOI:10.1371/journal.pmed.1004135]

3. Lyssenko V and Vaag A (2023) Genetics of diabetes-associated microvascular complications. Diabetologia, 66(9): 1601-1613. [DOI:10.1007/s00125-023-05964-x]

4. Georgianos PI, Vaios V, Eleftheriadis T, Papachristou E, Liakopoulos V (2023) Therapeutic Advances in Diabetic Kidney Disease. Int J Mol Sci, 24(3): 2803. [DOI:10.3390/ijms24032803]

5. Gupta S, Dominguez M, Golestaneh L (2023) Diabetic Kidney Disease: An Update. Med Clin North Am, 107(4): 689-705. [DOI:10.1016/j.mcna.2023.03.004]

6. Anil V, Turukmane A, Nawaf Alhebaishi B, Abdulrhman M, Alshareef (2022) Multispectral image analysis for monitoring by IoT based wireless communication using secure locations protocol and classification by deep learning techniques. Optik, 271: 170122. [DOI:10.1016/j.ijleo.2022.170122]

7. Anupong Wongchai A, Durga rao Jenjeti BA, Indira Priyadarsini (2022) Farm monitoring and disease prediction by classification based on deep leaming architectures in sustainable agriculture. Ecological Modelling, 474: 110167. [DOI:10.1016/j.ecolmodel.2022.110167]

8. Ahmad AA, Draves SO, Rosca M (2021) Mitochondria in Diabetic Kidney Disease. Cells, 10(11): 2945. [DOI:10.3390/cells10112945]

9. Xie F, Zhang T, Zhang P, Qu X, Li M, Lan W (2023) Shenkang injection combined with alprostadil for chronic renal failure: A systematic review and meta-analysis. Front Med (Lausanne), 10: 982016. [DOI:10.3389/fmed.2023.982016]

10. Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fernández C, Marchant V, Donate-Correa J, et al. (2023) Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int, 103(2): 282-296. [DOI:10.1016/j.kint.2022.10.030]

11. Liu Y, Wang S, Jin G, Gao K, Wang S, Zhang X, Zhou K, Cai Y, Zhou X, Zhao Z (2023) Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway. Phytomedicine, 118: 154915. [DOI:10.1016/j.phymed.2023.154915]

12. Arvind K, Nishant S, Arpit B (2022) Clinical risk assessment of chronic kidney disease patients using genetic programming. Computer Methods in Biomechanics and Biomedical Engineering, 25(8): 887-895. [DOI:10.1080/10255842.2021.1985476]

13. Chen R, Xu L, Zhang X, Sun G, Zeng W, Sun X (2022) Protective effect and mechanism of Shenkang injection on adenine-induced chronic renal failure in rats. Acta Cir Bras, 37(3): e370304. [DOI:10.1590/acb370304]

14. Luo LP, Suo P, Ren LL, Liu HJ, Zhang Y, Zhao YY (2021) Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways. Front Pharmacol, 12: 800522. [DOI:10.3389/fphar.2021.800522]

15. Mei J, Yang L, Wang D, Wang H (2021) Efficacy and safety of Shenkang injection in the treatment of chronic renal failure: A protocol of a randomized controlled trial. Medicine (Baltimore), 100(48): e27748. [DOI:10.1097/MD.0000000000027748]

16. Jiang X, Zhou L, Zuo L, Wang X, Shi Y, Du X, Zhang J, Liu L, Li Z, Xue L, Liu X, Sun Z (2020) Pharmacokinetics and Metabolism Research of Shenkang Injection in Rats Based on UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS. Drug Des Devel Ther, 14: 1837-1850. [DOI:10.2147/DDDT.S235646]

17. Qu Z, Wang B, Jin Y, Xiao Q, Zhao Y, Zhao D, Yang L (2023) Shenkang protects renal function in diabetic rats by preserving nephrin expression. BMC Complement Med Ther, 23(1): 244. [DOI:10.1186/s12906-023-04078-6]

18. Chu B, Chen Z, Shi H, Wu X, Wang H, Dong F, He Y (2023) Fluorescence, ultrasonic and photoacoustic imaging for analysis and diagnosis of diseases. Chem Commun (Camb), 59(17): 2399-2412. [DOI:10.1039/D2CC06654H]

19. Wilsen CB, Patel MK, Douek ML, Masamed R, Dittmar KM, Lu DSK, Raman SS (2023) Contrast-enhanced ultrasound for abdominal image-guided procedures. Abdom Radiol (NY), 48(4): 1438-1453. [DOI:10.1007/s00261-023-03804-5]

20. Yang L, Tao Y, Weixin Z, Meiling B, Jing H (2022) Contrast-enhanced and microvascular ultrasound imaging features of testicular lymphoma: report of five cases and review literature. BMC Urol, 22(1): 6. [DOI:10.1186/s12894-022-00957-1]

21. Harshit Bhardwaj, Pradeep Tomar, Aditi Sakalle (2021) EEG-Based Personality Prediction Using Fast FourierTransfoim and DeepLSTM Model. Comput Intell Neurosci, 20: 6524858. [DOI:10.1155/2021/6524858]

22. Fischer C, Krix M, Weber MA, Loizides A, Gruber H, Jung EM, Klauser A, Radzina M, Dietrich CF (2020) Contrast-Enhanced Ultrasound for Musculoskeletal Applications: A World Federation for Ultrasound in Medicine and Biology Position Paper. Ultrasound Med Biol, 46(6): 1279-1295. [DOI:10.1016/j.ultrasmedbio.2020.01.028]

23. Golemati S and Cokkinos DD (2022) Recent advances in vascular ultrasound imaging technology and their clinical implications. Ultrasonics, 119: 106599. [DOI:10.1016/j.ultras.2021.106599]

24. Ivanoski S, Vasilevska Nikodinovska V (2020) Future Ultrasound Biomarkers for Sarcopenia: Elastography, Contrast-Enhanced Ultrasound, and Speed of Sound Ultrasound Imaging. Semin Musculoskelet Radiol, 24(2): 194-200. [DOI:10.1055/s-0040-1701630]

25. Shao S, Yao M, Li X, Li C, Chen J, Li G, Jia C, Wu R (2021) Conventional and contrast-enhanced ultrasound features in sclerosing adenosis and correlation with pathology. Clin Hemorheol Microcirc, 77(2): 173-181. [DOI:10.3233/CH-200943]

26. Gui H, Chen X, Ye L, Ma H (2023) Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy. Acta Diabetol, 60(4): 493-505. [DOI:10.1007/s00592-022-02027-2]

27. Zou J, Zhou X, Chen X, Ma Y, Yu R (2022) Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction. Front Pharmacol, 13: 849832. [DOI:10.3389/fphar.2022.849832]

28. Wang YN, Liu HJ, Ren LL, Suo P, Zou L, Zhang YM, Yu XY, Zhao YY (2022) Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway. Front Pharmacol, 13: 964370. [DOI:10.3389/fphar.2022.964370]

29. Zhu J, Yang T, Luo J, Wei M, Li H, Qi Y, He J, Chen M (2022) Effects of Shenkang Injection Combined with Jinshuibao on Early Diabetic Nephropathy and Effects on Coagulation Fibrinolysis System and Urinary Protein. Evid Based Complement Alternat Med, ???? 3958049. [DOI:10.1155/2022/3958049]